|
1
|
Gan J, Li P, Wang Z, et al: Rosuvastatin
suppresses platelet-derived growth factor-BB-induced vascular
smooth muscle cell proliferation and migration via the MAPK
signaling pathway. Exp Ther Med. 6:899–903. 2013.PubMed/NCBI
|
|
2
|
Lacolley P, Regnault V, Nicoletti A, Li Z
and Michel JB: The vascular smooth muscle cell in arterial
pathology: a cell that can take on multiple roles. Cardiovasc Res.
95:194–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi N and Chen SY: Mechanisms
simultaneously regulate smooth muscle proliferation and
differentiation. J Biomed Res. 28:40–46. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng SD and Wu HJ: Progress of studies on
effects of ligustrazine on blood vessel endothelium protection.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 31:1004–1008. 2011.In Chinese.
PubMed/NCBI
|
|
5
|
Wang P, Luo CH, Wang QX, Li QY, Li P and
Yuan XH: Antithrombotic effect of ligustrazine hydrochloride
injection on the model of induced arteriovenous shunt thrombosis. J
Res Med Sci. 18:704–706. 2013.
|
|
6
|
Luo ZL, Tian FZ, Tang LJ, et al:
Protective effect of ligustrazine preconditioning on hepatic energy
metabolism in ischemia/reperfusion injury of rat. Sichuan Da Xue
Xue Bao Yi Xue Ban. 43:540–542. 2012.In Chinese.
|
|
7
|
Yu Y, Wang SR and Sun YK: Effects of
ligustrazine on the mitochondrial structure and functions in the
process myocardial hypertrophy. Zhongguo Zhong Xi Yi Jie He Za Zhi.
32:661–665. 2012.In Chinese. PubMed/NCBI
|
|
8
|
Rocchiccioli S, Ucciferri N, Comelli L,
Trivella MG, Citti L and Cecchettini A: Proteomics changes in
adhesion molecules: a driving force for vascular smooth muscle cell
phenotypic switch. Mol Biosyst. 8:1052–1059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Orr AW, Hastings NE, Blackman BR and
Wamhoff BR: Complex regulation and function of the inflammatory
smooth muscle cell phenotype in atherosclerosis. J Vasc Res.
47:168–180. 2010. View Article : Google Scholar :
|
|
10
|
Liu G, Li X, Li Y, et al: PPARdelta
agonist GW501516 inhibits PDGF-stimulated pulmonary arterial smooth
muscle cell function related to pathological vascular remodeling.
Biomed Res Int. 2013:9039472013. View Article : Google Scholar
|
|
11
|
Park ES, Lee KP, Jung SH, et al: Compound
K, an intestinal metabolite of ginsenosides, inhibits
PDGF-BB-induced VSMC proliferation and migration through G1 arrest
and attenuates neointimal hyperplasia after arterial injury.
Atherosclerosis. 228:53–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Conti V, Russomanno G, Corbi G, Izzo V,
Vecchione C and Filippelli A: Adrenoreceptors and nitric oxide in
the cardiovascular system. Front Physiol. 4:3212013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gibiino S1, Marsano A and Serretti A:
Specificity profile of venlafaxine and sertraline in major
depression: metaregression of double-blind, randomized clinical
trials. Int J Neuropsychopharmacol. 17:1–8. 2014. View Article : Google Scholar
|
|
14
|
Lim S and Kaldis P: Cdks, cyclins and
CKIs: roles beyond cell cycle regulation. Development.
140:3079–3093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sroka IM, Heiss EH, Havlicek L, et al: A
novel roscovitine derivative potently induces G1-phase arrest in
platelet-derived growth factor-BB-activated vascular smooth muscle
cells. Mol Pharmacol. 77:255–261. 2010. View Article : Google Scholar
|
|
16
|
Pi Y, Zhang LL, Li BH, et al: Inhibition
of reactive oxygen species generation attenuates TLR4-mediated
proinflammatory and proliferative phenotype of vascular smooth
muscle cells. Lab Invest. 93:880–887. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang XL, Liu LF, Zhu LY, et al: A high
performance liquid chromatography fingerprinting and ultra high
performance liquid chromatography coupled with quadrupole
time-of-flight mass spectrometry chemical profiling approach to
rapidly find characteristic chemical markers for quality evaluation
of dispensing granules, a case study on Chuanxiong Rhizoma. J Pharm
Biomed Anal. 88:391–400. 2014. View Article : Google Scholar
|
|
18
|
Fan Z, Li C, Qin C, et al: Role of the
PI3K/AKT pathway in modulating cytoskeleton rearrangements and
phenotype switching in rat pulmonary arterial vascular smooth
muscle cells. DNA Cell Biol. 33:12–19. 2014. View Article : Google Scholar
|
|
19
|
Karki R, Kim SB and Kim DW: Magnolol
inhibits migration of vascular smooth muscle cells via cytoskeletal
remodeling pathway to attenuate neointima formation. Exp Cell Res.
319:3238–3250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kobsar A, Klinker E, Kuhn S, et al:
Increasing susceptibility of nitric oxide-mediated inhibitory
platelet signaling during storage of apheresis-derived platelet
concentrates. Transfusion. 54:1782–1789. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qian J and Fulton D: Post-translational
regulation of endothelial nitric oxide synthase in vascular
endothelium. Front Physiol. 4:3472013. View Article : Google Scholar :
|
|
22
|
Yoon J and Ryoo S: Arginase inhibition
reduces interleukin-1beta-stimulated vascular smooth muscle cell
proliferation by increasing nitric oxide synthase-dependent nitric
oxide production. Biochem Biophys Res Commun. 435:428–433. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ataya B, Tzeng E and Zuckerbraun BS:
Nitrite-generated nitric oxide to protect against intimal
hyperplasia formation. Trends Cardiovasc Med. 21:157–162. 2011.
View Article : Google Scholar
|
|
24
|
Yao M, Roberts DD and Isenberg JS:
Thrombospondin-1 inhibition of vascular smooth muscle cell
responses occurs via modulation of both cAMP and cGMP. Pharmacol
Res. 63:13–22. 2011. View Article : Google Scholar :
|
|
25
|
Kim EK and Choi EJ: Pathological roles of
MAPK signaling pathways in human diseases. Biochim Biophys Acta.
1802:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Muslin AJ: MAPK signalling in
cardiovascular health and disease: molecular mechanisms and
therapeutic targets. Clin Sci (Lond). 115:203–218. 2008. View Article : Google Scholar
|
